Janssen Pharmaceutica selects Qumas

Dateline: 25 April 2005

QUMAS, the leading provider of enterprise risk and compliance management software solutions for regulated industries, today announced that Janssen Pharmaceutica, based in Belgium, has selected the QCompliance Suite as a single solution to ensure compliance across a broad range of regulatory requirements for the pharmaceutical manufacturing plants in Europe and the chemical manufacturing plants worldwide.

Janssen Pharmaceutica is the first of the world’s leading pharmaceutical companies to choose a single vendor to address both document and process management.

The QUMAS QCompliance Suite is a complete compliance framework that allows firms in highly regulated industries to initiate enterprise wide compliance programs covering many regulations with a single solution. The QCompliance Suite eliminates the need for firms to have a number of point solutions that only cover one specific regulation.

“We chose QUMAS because its comprehensive compliance suite uniquely allowed us to install a single solution that we would previously have sourced from two or more vendors,” said Bert Jacobs, Director European Pharma QA Information Management, at Janssen Pharmaceutica. “The QUMAS QCompliance Suite provides the company with a scalable compliance framework that can be rapidly rolled out across multiple divisions.”

“We are excited to have Janssen Pharmaceutica on board as a customer,” said Kevin O’Leary, President of QUMAS. “Up to this point the industry has relied on different vendors to provide content solutions and process solutions. By selecting QUMAS, Janssen Pharmaceutica has reflected a maturing of the sector in dealing with compliance. It solidifies the QCompliance Suite as the framework that will set the agenda for compliance standards going forward. Customers like Janssen Pharmaceutica are our proof points. We are now a key supplier to four of the top five pharmaceutical companies in the world.”